New Jersey Business NJ

Catalent acquires U.K. Vaccine Manufacturing and Innovation Centre to expand biologics

Return On Information New Jersey

Apr 6, 2022

Biopharma leader Catalent acquired the Vaccine Manufacturing and Innovation Centre, also known as VMIC Ltd., which is currently under construction near Oxford, U.K., according to a…

Read the full story at Return On Information New Jersey

Catalent acquires U.K. Vaccine Manufacturing and Innovation Centre to expand biologics

More from New Jersey Business

Statement: Sherrill administration should have delayed New Jersey's new independent contractor regulations

New Report Says N.J. Needs More Affordable Homes for Sale, Not Just Buyer Assistance

100,000 Square Foot Expansion Breaks Ground at Liberty Science Center

Panoramic Manhattan Views and a Private Terrace Define This Avora Residence

New Jersey cannot afford to send mixed signals to business

Team Moza Debuts Casa One, Featuring 196 Rental Residences in Journal Square

Princeton Community Housing to Build Affordable Apartments on Former DPW Site

All-Affordable 113-Unit Development Moves Forward in Wayne